Inhibitor Therapeutics, Inc.
INTI
$0.05
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -53.33% | -47.34% | -43.74% | -36.57% | -33.12% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 19.56% | 23.32% | -11.83% | -19.60% | 4.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -52.50% | -46.61% | -43.28% | -36.37% | -32.85% |
|
|
|||||
| Total Current Assets | -52.50% | -46.61% | -43.28% | -36.37% | -32.85% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -51.40% | -45.53% | -42.20% | -36.37% | -32.85% |
|
|
|||||
| Total Accounts Payable | 1,052.94% | 464.89% | -67.20% | -52.82% | -98.17% |
| Total Accrued Expenses | -5.83% | -53.89% | -27.11% | 9.87% | -32.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 96.19% | 294.37% | -39.26% | 6.67% | -71.48% |
|
|
|||||
| Total Current Liabilities | 96.19% | 294.37% | -39.26% | 6.67% | -71.48% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 2.86% | 5.16% | -0.09% | 1.21% | -3.54% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.04% | 0.00% | 0.07% | 0.07% |
| Retained Earnings | -6.76% | -6.90% | -6.65% | -6.85% | -6.48% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -99.90% | -82.71% | -70.85% | -62.43% | -47.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -99.90% | -82.71% | -70.85% | -62.43% | -47.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -99.90% | -82.71% | -70.85% | -62.43% | -47.19% |
|
|
|||||